Phase I study of AMG 211/MEDI-565 administered as continuous intravenous infusion (cIV) for relapsed/refractory gastrointestinal (GI) adenocarcinoma

Authors :: C. W. Menke-van der Houven van Oordt
Kirsten L. Moek
Thomas J. Ettrich
Erik Rasmussen
B. Sable
E.G.E. de Vries
Maxim Kebenko
Derk Jan A. de Groot
H. M. W. Verheul
Volker Heinemann
J. C. von Einem
P. Bogner
Sabine Stienen
Walter Fiedler
Thomas Seufferlein
CCA - Cancer biology and immunology
CCA - Imaging and biomarkers
CCA - Treatment and quality of life
Medical oncology
Source :: Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii139-viii140. Oxford University Press, Moek, K L, Fiedler, W M, von Einem, J C, Verheul, H M, Seufferlein, T, de Groot, D J, Heinemann, V, Kebenko, M, Menke-van der Houven van Oordt, C W, Ettrich, T J, Rasmussen, E, Bogner, P, Sable, B, Stienen, S & de Vries, E G E 2018, ' Phase I study of AMG 211/MEDI-565 administered as continuous intravenous infusion (cIV) for relapsed/refractory gastrointestinal (GI) adenocarcinoma ', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii139-viii140 . https://doi.org/10.1093/annonc/mdy279.414
Publication Year :: 2018

Subjects :: 0301 basic medicine
medicine.medical_specialty
Hematology
business.industry
Phases of clinical research
medicine.disease
Gastroenterology
Phase i study
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Oncology
030220 oncology & carcinogenesis
Internal medicine
Relapsed refractory
medicine
Adenocarcinoma
business

Language :: English
ISSN :: 09237534
Database :: OpenAIRE
Journal :: Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii139-viii140. Oxford University Press, Moek, K L, Fiedler, W M, von Einem, J C, Verheul, H M, Seufferlein, T, de Groot, D J, Heinemann, V, Kebenko, M, Menke-van der Houven van Oordt, C W, Ettrich, T J, Rasmussen, E, Bogner, P, Sable, B, Stienen, S & de Vries, E G E 2018, ' Phase I study of AMG 211/MEDI-565 administered as continuous intravenous infusion (cIV) for relapsed/refractory gastrointestinal (GI) adenocarcinoma ', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii139-viii140 . https://doi.org/10.1093/annonc/mdy279.414
Accession number :: edsair.doi.dedup.....1ef775642299bb732be0662b5725165f

Tools